Mission and History

Mission and History

Our Goal

We are committed to discovering novel therapies for substantially unmet medical needs by applying our expertise in computational science, synthetic chemistry, molecular and cellular biology, and pharmacology. Our uniqueness and our core competencies reflect 50 years of experience creating and managing biomedical knowledge.

History

Prous Institute for Biomedical Research is a privately owned drug discovery company located in Barcelona. Prous Institute was founded by Dr. J.R. Prous in 2000 with the goal of discovering new drugs using computational tools and methods (SYMMETRY®) to predict drug safety and efficacy, alongside expertise in organic synthesis and laboratory and animal studies. J.R. Prous is highly experienced in drug discovery and was the founder, CEO and President of Prous Science (1965-2007), the originator of the well-known MDDR and Integrity databases. Prous Science was acquired by Thomson Reuters in 2007.